|Opioid overdose is the second leading cause of unintentional deaths in the US.
|of the world’s opioids are used
|of medication overdose deaths
in 2010 were related to opioid drugs.
Braeburn Pharmaceuticals, a commercial stage pharmaceutical company, focuses on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain, and schizophrenia.
This is where it all starts.
Braeburn makes it possible for independent minds, trailblazers and innovators to work together in a unique environment that encourages innovation and discovery. We believe this is the difference that makes a difference.
Perhaps it’s the promise that our vision can actually be attained. Not through politics or committees, but through mutual understanding, drive, and purpose.
Every day, we’re reevaluating and rethinking a new way forward… to redefine treatment.
Braeburn is thinking beyond what’s been done. And thinking about what can be done, what is possible…
October 24, 2016
October 21, 2016
September 30, 2016
July 19, 2016